'Prac­ti­cal­ly clean' FDA user fees reauth will be in­clud­ed in spend­ing bill wrap­ping up next week

The long and wind­ing road to reau­tho­riz­ing FDA’s quin­quen­ni­al user fees for pre­scrip­tion drugs, gener­ics, biosim­i­lars and med­ical de­vices fi­nal­ly has a light at the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.